Compare Airbnb, Inc. (ABNB) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Airbnb, Inc. vs Summit Therapeutics Inc — how do they compare? Airbnb, Inc. trades at $179.96 (market cap $110.76B), while Summit Therapeutics Inc trades at $15.1 (market cap $12.06B). The key difference: Airbnb, Inc. is far larger — about 9.2× Summit Therapeutics Inc's market cap, and Airbnb, Inc. is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| ABNB | SMMT | |
|---|---|---|
Market Cap | $110.76B | $12.06B |
Sector | Consumer Cyclical | Health |
52-Week High | $184.98 | $26.98 |
52-Week Low | $111.54 | $12.55 |
Enterprise Value | $101.19B | $11.39B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABNB trades at $179.40, down 2.87% over 24 hours, with a bullish technical outlook from moving averages but overbought RSI signals. The company reported Q2 2026 EPS of $1.37, beating expectations, and revenue growth continues with a 20.45% net income margin. Recent news highlights AI-driven growth and expansion into hotels and travel services.
Outlook is positive with strong analyst support and AI integration boosting efficiency, but high valuation ratios and competitive pressures pose risks. The consensus price target is $173.26, slightly below current price, indicating cautious optimism amid growth momentum.
Summit Therapeutics (SMMT) trades at $15.23, up 2.42% today, with a bullish technical signal and strong analyst consensus. The stock shows mixed earnings performance but benefits from positive news on ivonescimab's regulatory progress and clinical expansions. Despite negative profitability metrics, investor sentiment is buoyed by a high price target of $38.00 and recent partnership announcements in cancer drug development.
Outlook hinges on FDA approval for ivonescimab by November 2026, offering significant upside if successful. Risks include cash burn, ongoing losses, and fiduciary investigations. The stock presents a high-risk, high-reward opportunity for speculative investors betting on clinical successes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Airbnb, Inc.
Airbnb, Inc. operates an online marketplace for travel information and booking services. The Company offers lodging, home stay, and tourism services via websites and mobile applications. Airbnb serves clients worldwide.
Read more on ABNB →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
